ASML reported better-than-expected Q1 earnings, with $8.82B in revenue and a 54% gross margin. Read why I remain very bullish ...

It is scheduled to announce its fiscal Q4 earnings for 2025 after the market closes on Tuesday, Jun. 24. Ahead of this event, ...

For the Nifty 50 Index, consolidation may continue in the short term, especially as the index has yet to give a decisive ...

Iovance Biotherapeutics (NASDAQ: IOVA) and CRISPR Therapeutics (NASDAQ: CRSP) are two incredibly innovative biotechs, but ...